183 results
Page 3 of 10
8-K
EX-10.1
k8jyitcf
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
424B5
dkracp 0212bqrf
10 Mar 20
Prospectus supplement for primary offering
3:04pm
8-K
EX-10.1
2bf7paltpchybfjw5wdv
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
424B5
gsigcjult4a ar4
28 Feb 20
Prospectus supplement for primary offering
1:27pm
424B5
jtk158ppi qnv4z72ngf
31 Jan 20
Prospectus supplement for primary offering
8:03am
8-K
EX-10.1
aua l6y99zy5ljg
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
424B5
cq9e3
31 Jan 20
Prospectus supplement for primary offering
8:01am
424B5
ef67fik5mm8e 5mp
31 Oct 19
Prospectus supplement for primary offering
4:05pm
424B5
61whbi9amb5vgr
31 Oct 19
Prospectus supplement for primary offering
4:02pm
8-K
EX-1.1
vkl3m 568ifd
31 Oct 19
Entry into a Material Definitive Agreement
9:29am
424B5
z0piqw izi
30 Oct 19
Prospectus supplement for primary offering
4:59pm
8-K
EX-1.1
htdrp71u
30 Oct 19
Entry into a Material Definitive Agreement
4:38pm